|4May 14, 5:00 PM ET

JUNIUS DANIEL M 4

4 · IDEXX LABORATORIES INC /DE · Filed May 14, 2025

Insider Transaction Report

Form 4
Period: 2025-05-13
Transactions
  • Exercise/Conversion

    Common Stock

    2025-05-13$245.79/sh+1,404$345,0894,708 total
  • Exercise/Conversion

    Common Stock

    2025-05-13$283.59/sh+1,279$362,7125,987 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right-to-buy)

    2025-05-131,4040 total
    Exercise: $245.79Exp: 2029-05-07Common Stock (1,404 underlying)
  • Sale

    Common Stock

    2025-05-13$506.41/sh2,683$1,358,6973,304 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right-to-buy)

    2025-05-131,2790 total
    Exercise: $283.59Exp: 2030-05-05Common Stock (1,279 underlying)
Footnotes (2)
  • [F1]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2020 annual meeting of shareholders, whichever event was earlier.
  • [F2]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event was earlier.

Documents

1 file
  • 4
    wk-form4_1747256407.xmlPrimary

    FORM 4